Avanos Medical (AVNS) Common Equity (2016 - 2024)
Historic Common Equity for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $1.2 billion.
- Avanos Medical's Common Equity rose 62.19% to $1.2 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 billion, marking a year-over-year increase of 62.19%. This contributed to the annual value of $1.2 billion for FY2023, which is 425.19% down from last year.
- Latest data reveals that Avanos Medical reported Common Equity of $1.2 billion as of Q3 2024, which was up 62.19% from $1.2 billion recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Common Equity registered a high of $1.3 billion during Q1 2023, and its lowest value of $1.2 billion during Q2 2024.
- In the last 5 years, Avanos Medical's Common Equity had a median value of $1.3 billion in 2020 and averaged $1.3 billion.
- In the last 5 years, Avanos Medical's Common Equity surged by 335.85% in 2023 and then tumbled by 545.16% in 2024.
- Avanos Medical's Common Equity (Quarter) stood at $1.3 billion in 2020, then grew by 0.67% to $1.3 billion in 2021, then grew by 1.62% to $1.3 billion in 2022, then fell by 4.25% to $1.2 billion in 2023, then decreased by 0.53% to $1.2 billion in 2024.
- Its Common Equity stands at $1.2 billion for Q3 2024, versus $1.2 billion for Q2 2024 and $1.2 billion for Q1 2024.